European agency finds AstraZeneca can cause rare blood clots, but benefits outweigh risks

The safety committee of the European Medicines Agency (EMA) has found that the Oxford-AstraZeneca Covid-19 vaccine can cause unusual blood clots with low blood platelets, but stresses the overall benefits of the vaccine in preventing coronavirus outweigh the risks of side effects.

Share:

Facebook
Twitter
Pinterest
LinkedIn

Leave a Reply

Related Posts

Must-Have Lifestyle Items in 2024

As we embrace 2024, staying ahead of the curve in lifestyle trends is key to enhancing our day-to-day living. From tech gadgets to home essentials,

Top 5 Investment Ideas for 2024

As we step into 2024, the investment landscape offers a mix of challenges and opportunities. With careful planning and strategic thinking, you can position your